Tykerb
Tykerb ingredients
| Active ingredient | Strength |
|---|---|
| Lapatinib Ditosylate | 250 mg/1 |
What Tykerb is used for
The FDA lists the approved uses on the official label (below). In the EU, lapatinib is approved as Tyverb for:
Tyverb is indicated for the treatment of patients with breast cancer, whose tumours overexpress HER2 (ErbB2): in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting; in combination with trastuzumab for patients with hormone-receptor-negative metastatic disease that has progressed on prior trastuzumab therapy or therapies in combination with chemotherapy; in combination with an aromatase inhibitor for post-menopausal women with hormone-receptor-positive metastatic disease, not currently intended for chemotherapy. The patients in the registration study had not previously been treated with trastuzumab or an aromatase inhibitor. No data are available on the efficacy of this combination relative to trastuzumab in combin…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Tykerb
- Generic name
- Lapatinib
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Tablet
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA022059
- On the US market since
- 2016
Official information
- Tykerb prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Lapatinib)
In India
- Lapatinib ditosylate: 11 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tykerb?
Tykerb (Lapatinib) is a cancer medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Tykerb?
Tykerb contains Lapatinib Ditosylate (250 mg/1).
Is Tykerb approved in Europe?
The same active substance is approved in the EU as Tyverb.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA